Ticker

Koninklijke Ahold Delhaize N.V. is upgraded to “Buy” after a valuation-driven decline of over 18%, with fundamentals remaining robust. At €30.65/share (~11.2x P/E), ADRNY offers over 15% annualized upside to a €32/share target, supported by stable margins and conservative growth. Operational performance is steady, with 2Q26 revenues up 2%, margins near 4%, and CapEx intensity a key watchpoint.

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Clorox (CLX). But which of these two stocks offers value investors a better bang for their buck right now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Ahold Delhaize is a leading global grocery retailer offering stable, counter-cyclical returns through dividends, buybacks, and steady growth. ADRNY's fair valuation reflects a forward P/E of 11.4x, with the share price recently correcting from overvalued levels and now hovering near key support. Growth drivers include network expansion, private label penetration (targeting 45% by 2028), e-commerce profitability, and…

Koninklijke Ahold Delhaize N.V. (ADRNY) Q2 2026 Earnings Call Transcript